Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

[Transcutaneous auricular vagus nerve stimulation for anxiety and depression in Parkinson's disease with liverkidney yin deficiency: a randomized controlled trial].

Created on 17 Nov 2026

Authors

Mimi Li, Lifeng Zhou, Shaochang Wu, Jincheng Ma

Published in

Zhongguo zhen jiu = Chinese acupuncture & moxibustion. Volume 46. Issue 11. Pages 1789-1795. Nov 12, 2026. Epub Sep 10, 2026.

Abstract

To observe the clinical efficacy of transcutaneous auricular vagus nerve stimulation (taVNS) in treating anxiety and depression in Parkinson's disease (PD) patients with liver-kidney yin deficiency.
A total of 132 PD patients with anxiety and depression of liver-kidney yin deficiency were randomized into an observation group (66 cases, 3 cases dropped out) and a control group (66 cases, 5 cases dropped out). Conventional western medicine treatment was given in the control group. On the basis of the treatment in the control group, in the observation group, taVNS was applied at the left cymba concha, the international standardized auricular acupoint area-10 (CO10 [shen]) and area-12 (CO12 [gan]) were selected, the stimulation lasted 30 min, once daily, 5 times a week, with 2-day interval. The treatment for 4 continuous weeks was given in both groups. Before and after treatment, as well as at the follow-up of 12 weeks after treatment completion, the scores of Hamilton depression scale (HAMD), Hamilton anxiety scale (HAMA), TCM syndrome, unified Parkinson's disease rating scale-part Ⅲ (UPDRS-Ⅲ), and 39-item Parkinson's disease questionnaire (PDQ-39) were observed, and the clinical efficacy was assessed after treatment in the two groups.
Compared before treatment, the scores of HAMD, HAMA, TCM syndrome and PDQ-39 were decreased after treatment and at follow-up (P<0.001, P<0.05, P<0.01); the above indexes in the observation group were lower than those in the control group after treatment and at follow-up (P<0.05). There were no statistically significant differences in the UPDRS-Ⅲ scores between the two groups at each time point before and after treatment (P>0.05). The total effective rate in the observation group was 93.7% (59/63), which was higher than 73.8% (45/61) in the control group (P<0.05).
taVNS can relieve anxiety-depression symptoms and TCM syndromes, and improve quality of life in PD patients with anxiety and depression of liver-kidney yin deficiency.

PMID:
43039833
Bibliographic data and abstract were imported from PubMed on 17 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 6
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement